Skip to content
OpenCapital
Get started

OraSure Technologies OSUR Equity Securities (FV-NI) - Non-Current

Equity Securities (FV-NI) - Non-Current at other companies

Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
——

Other financials

Income statement

See full
Revenue$27.9M-6.7%
Gross profit$11.8M-4.0%
Operating income-$23.3M-31.1%
Net income-$22.4M-39.5%
EPS (diluted)-$0.32-52.4%

Balance sheet

See full
Cash & equivalents$177.0M-28.5%
Total debt$12.7M-10.9%
Total equity$313.3M-20.9%
Total assets$379.2M-17.1%

Cash flow

See full
Operating cash flow-$13.9M+29.6%
CapEx$913.0K+117%
Free cash flow-$14.8M+26.5%

Valuation

See full
Market cap$303.62M+35.3%
Enterprise value$139.32M-1,654%
P/S2.7×+1.3×

Profitability

See full
Gross margin42.2%+0.4pp
Operating margin-68.6%-149pp
Net margin-66.4%-115pp
FCF margin-42.4%-43.3pp

Returns & leverage

See full
Return on equity-21.2%-50.4pp
Debt / equity0×0.0×
Current ratio5.5×-6.9×

Where this comes from

Reported directly by OraSure Technologies in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFVNINoncurrent.

The official record: OraSure Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OraSure Technologies's equity securities (fv-ni) - non-current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OraSure Technologies's equity securities (FV-NI) - non-current?
OraSure Technologies (OSUR) reported equity securities (FV-NI) - non-current of $24.87M in Q1 2026.
How has OraSure Technologies's equity securities (FV-NI) - non-current changed year-over-year?
OraSure Technologies's equity securities (FV-NI) - non-current decreased by 10.5% year-over-year, from $27.78M to $24.87M.